Dangerous Drugs - Raptiva

In July 2005, the FDA unveiled a new warning for the Genentech-produced psoriasis drug Raptiva (efalizumab) following reports of four cases of hemolytic anemia. Each case was diagnosed four to six months after patients began using the drug.

In two severe cases outlined in a "Dear Healthcare Provider" letter issued by Genetech, Raptiva was shown to potentially cause hemoglobin levels to plummet. The packaging of the drug has since been modified to include a warning describing these dangerous side effects.

If you or a loved one has suffered an injury, illness or death, that seems to have been someone else’s fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.